Movement Alert｜Xenon Pharmaceuticals Rises 7.25% in Regular Trading, Trading at $68.07

Market Focus07-09

On July 8, Xenon Pharmaceuticals rose 7.25% in regular trading, trading at $68.07 USD/share, with Turnover of $124 million.

Within the Biotechnology sector where Xenon Pharmaceuticals belongs, individual stocks showed mixed performance. Among major sector constituents, Amgen up 0.24%, AbbVie down 0.15%, Gilead Sciences down 0.33%, Vertex Pharmaceuticals down 2.98%, Moderna down 6.35%.

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on neuroscience, developing therapeutics for neurological disorders. Its pipeline includes Azetukalner (XEN1101), a Kv7 potassium channel opener for epilepsy treatment, for which the company plans to submit a new drug application to the FDA in Q3.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100985461?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-09 02:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100985461","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Xenon Pharmaceuticals Rises 7.25% in Regular Trading, Trading at $68.07","media":"Market Focus","content":"<p><p>On July 8, Xenon Pharmaceuticals rose 7.25% in regular trading, trading at $68.07 USD/share, with Turnover of $124 million.</p><p>Within the Biotechnology sector where Xenon Pharmaceuticals belongs, individual stocks showed mixed performance. Among major sector constituents, Amgen up 0.24%, AbbVie down 0.15%, Gilead Sciences down 0.33%, Vertex Pharmaceuticals down 2.98%, Moderna down 6.35%.</p><p>Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on neuroscience, developing therapeutics for neurological disorders. Its pipeline includes Azetukalner (XEN1101), a Kv7 potassium channel opener for epilepsy treatment, for which the company plans to submit a new drug application to the FDA in Q3.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Xenon Pharmaceuticals Rises 7.25% in Regular Trading, Trading at $68.07</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Xenon Pharmaceuticals Rises 7.25% in Regular Trading, Trading at $68.07\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-09 02:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 8, Xenon Pharmaceuticals rose 7.25% in regular trading, trading at $68.07 USD/share, with Turnover of $124 million.</p><p>Within the Biotechnology sector where Xenon Pharmaceuticals belongs, individual stocks showed mixed performance. Among major sector constituents, Amgen up 0.24%, AbbVie down 0.15%, Gilead Sciences down 0.33%, Vertex Pharmaceuticals down 2.98%, Moderna down 6.35%.</p><p>Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on neuroscience, developing therapeutics for neurological disorders. Its pipeline includes Azetukalner (XEN1101), a Kv7 potassium channel opener for epilepsy treatment, for which the company plans to submit a new drug application to the FDA in Q3.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XENE","symbol_name":"Xenon制药","start_time":0,"source_url":"","article_id":"1100985461","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100985461","pubTimestamp":1783535920,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 8, Xenon Pharmaceuticals rose 7.25% in regular trading, trading at $68.07 USD/share, with Turnover of $124 million.Within the Biotechnology sector where Xenon Pharmaceuticals belongs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XENE":"Xenon制药"},"translate_title":"走势提示|Xenon Pharmaceuticals常规交易上涨7.25%，报68.07美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XENE":1},"content_text":"On July 8, Xenon Pharmaceuticals rose 7.25% in regular trading, trading at $68.07 USD/share, with Turnover of $124 million.Within the Biotechnology sector where Xenon Pharmaceuticals belongs, individual stocks showed mixed performance. Among major sector constituents, Amgen up 0.24%, AbbVie down 0.15%, Gilead Sciences down 0.33%, Vertex Pharmaceuticals down 2.98%, Moderna down 6.35%.Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on neuroscience, developing therapeutics for neurological disorders. Its pipeline includes Azetukalner (XEN1101), a Kv7 potassium channel opener for epilepsy treatment, for which the company plans to submit a new drug application to the FDA in Q3.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100985461","isCrawlerRequest":true}